$クリアポイント ニューロ(CLPT.US)$ NEWS ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore SOLANA BEACH, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it will present novel research and exhibit at the27th American Society of Gene & Cell Therapy Annual Meetingto be hel...
$クリアポイント ニューロ(CLPT.US)$Damn just no volume! Guess FDA ok on stuff for bones dont rate as great as a pill or a shot the deal with the most rare of diseases of all to fight! OVERWEIGHT! Hehehe
Trytosaveabitスレ主Jaguar8:
How did I know you would! Oh yeah that’s right! You have witnessed first hand how the advancement of the super rare and extremely hard to treat weight loss drugs move The price on the very slightest of good PR! Again because of how hard it is to treat? Even a tiny bit of good news is met with powerful price movements! Hehehe
Jaguar8Trytosaveabitスレ主:
Oh yes even on just preclinical stage, the overweight study flies! Its obsession with overweight studies tied with obsession with obesity -inducing lifestyle and I’m not saying lifestyle is the only cause of obesity but it is the MAJOR factor.
$クリアポイント ニューロ(CLPT.US)$ NEWS ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations SOLANA BEACH, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today congratulates its partner AviadoBio on treating its first patie...
Analysts predict ClearPoint Neuro's growth rate to speed up, with an anticipated 26% annual revenue growth by end of 2024, surpassing its past five years' 21% p.a. growth. They also foresee ClearPoint Neuro outpacing the broader industry.
$クリアポイント ニューロ(CLPT.US)$ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model 4 MINUTES AGO, 4:05 PM EST VIA GLOBENEWSWIRE
$クリアポイント ニューロ(CLPT.US)$ClearPoint Neuro Reveals Receipt Of European Medical Device Regulation Clearance For The Manual SmartTwist MR Hand Drill And SmartTip MR Drill Kit Moomoo 24/7· just
ClearPoint Neuro's high P/S ratio suggests strong future growth and a confident investor outlook for the company's future revenues, making a steep fall in share price unlikely.
クリアポイント ニューロに関するコメント
NEWS
ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore
SOLANA BEACH, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it will present novel research and exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting to be hel...
ClearPoint Neuro Received FDA Clearance For Prism Bone Anchor Accessory
NEWS
ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
SOLANA BEACH, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today congratulates its partner AviadoBio on treating its first patie...
4 MINUTES AGO, 4:05 PM EST
VIA GLOBENEWSWIRE
Moomoo 24/7· just
まだコメントはありません